Doganis Dimitrios, Siafas Konstantinos, Mavrikou Myrsini, Issaris George, Martirosova Anna, Perperidis Grigorios, Konstantopoulos Andreas, Sinaniotis Konstantinos
First Department of Pediatrics, P&A Kyriakou Children's Hospital, Athens, Greece.
Pediatrics. 2007 Oct;120(4):e922-8. doi: 10.1542/peds.2006-2417. Epub 2007 Sep 17.
Therapeutic delay has been suggested as the most important factor that is likely to have an effect on the development of scarring after acute pyelonephritis. However, this opinion has not been supported by prospective studies, so we tested it.
In a prospective clinical study, we evaluated whether the time interval between the onset of the renal infection and the start of therapy correlates with the development of acute inflammatory changes and the subsequent development of renal scars, documented by dimercaptosuccinic acid scintigraphy. A total of 278 infants (153 male and 125 female) aged 0.5 to 12.0 months with their first urinary tract infection were enrolled in the study.
The median time between the onset of infection and the institution of therapy was 2 days (range: 1-8 days). Renal inflammatory changes were documented in 57% of the infants. Renal defects were recorded in 41% of the patients treated within the first 24 hours since the onset of fever versus 75% of those treated on day 4 and onward. Renal scarring was developed in 51% of the infants with an abnormal scan in the acute phase of infection. The frequency of scarring in infants treated early and in those whose treatment was delayed did not differ, suggesting that once acute pyelonephritis has occurred, ultimate renal scarring is independent of the timing of therapy. Acute inflammatory changes and subsequent scarring were more frequent in the presence of vesicoureteral reflux, especially that which is high grade. However, the difference was not significant, which suggests that renal damage may be independent of the presence of reflux.
Early and appropriate treatment of urinary tract infection, especially during the first 24 hours after the onset of symptoms, diminishes the likelihood of renal involvement during the acute phase of the infection but does not prevent scar formation.
治疗延迟被认为是可能影响急性肾盂肾炎后瘢痕形成的最重要因素。然而,这一观点尚未得到前瞻性研究的支持,因此我们对此进行了验证。
在一项前瞻性临床研究中,我们评估了肾脏感染发作与开始治疗之间的时间间隔是否与急性炎症变化的发展以及随后通过二巯基丁二酸闪烁扫描记录的肾脏瘢痕形成有关。共有278名年龄在0.5至12.0个月之间首次发生尿路感染的婴儿(153名男性和125名女性)纳入本研究。
感染发作与开始治疗之间的中位时间为2天(范围:1 - 8天)。57%的婴儿有肾脏炎症变化记录。在发热开始后的前24小时内接受治疗的患者中,41%有肾脏缺损记录,而在第4天及以后接受治疗的患者中这一比例为75%。在感染急性期扫描异常的婴儿中,51%出现了肾脏瘢痕形成。早期治疗的婴儿和治疗延迟的婴儿瘢痕形成频率没有差异,这表明一旦发生急性肾盂肾炎,最终的肾脏瘢痕形成与治疗时机无关。在存在膀胱输尿管反流尤其是重度反流时,急性炎症变化和随后的瘢痕形成更为常见。然而,差异并不显著,这表明肾脏损害可能与反流的存在无关。
早期且适当治疗尿路感染,尤其是在症状出现后的前24小时内,可降低感染急性期肾脏受累的可能性,但不能预防瘢痕形成。